The use of ticagrelor in a patient at increased risk of stent thrombosis resistant to multiple thienopyridines

Cardiology

Volumn 119, Issue 2, 2011, Pages 88-89

  Morgan, Kenneth P ^a   More, Ranjit S ^b   Chauhan, Anoop ^b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b BLACKPOOL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Acute myocardial infarction; Percutaneous coronary intervention; Platelet resistance; Thienopyridines; Ticagrelor

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PRASUGREL; THIENOPYRIDINE DERIVATIVE; TICAGRELOR;

AGED; ANGIOPLASTY; AORTA BALLOON; CARDIAC PATIENT; CARDIOGENIC SHOCK; CASE REPORT; HEART HEMODYNAMICS; HEART INFARCTION; HUMAN; MALE; PRIORITY JOURNAL; REVIEW; ST SEGMENT ELEVATION; STENT THROMBOSIS; THROMBOCYTE AGGREGATION INHIBITION;

ADENOSINE; AGED, 80 AND OVER; DRUG-ELUTING STENTS; HEART CATHETERIZATION; HUMANS; MALE; MYOCARDIAL INFARCTION; PURINERGIC P2Y RECEPTOR ANTAGONISTS; THIENOPYRIDINES; THROMBOSIS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 80052590942     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000329916     Document Type: Review

References (5)

1. Gaglia MA Jr, Waksman R: Overview of the 2010 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee meeting regarding ticagrelor. Circulation 2011; 123: 451-456.
2. Gurbel PA, Bliden KP: Interpretation of platelet inhibition by clopidogrel and the effect of non-responders. J Thromb Haemost 2003; 1: 1318-1319.
3. Gurbel PA, Bliden KP, Butler K, Antonino MJ, Wei C, Teng R, Rasmussen L, Storey RF, Nielsen T, Eikelboom JW, Sabe-Affaki G, Husted S, Kereiakes DJ, Henderson D, Patel DV, Tantry US: Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: The RESPOND study. Circulation 2010; 121: 1188-1199.
4. Cannon CP, Harrington RA, James S, Ardissino D, Becker RC, Emanuelsson H, Husted S, Katus H, Keltai M, Khurmi NS, Kontny F, Lewis BS, Steg PG, Storey RF, Wojdyla D, Wallentin L; PLATelet inhibition and patient Outcomes Investigators: Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): A randomised doubleblind study. Lancet 2010; 375: 283-293.
5. Steg PG, James S, Harrington RA, Ardissino D, Becker RC, Cannon CP, Emanuelsson H, Finkelstein A, Husted S, Katus H, Kilhamn J, Olofsson S, Storey RF, Weaver WD, Wallentin L; PLATO Study Group: Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Circulation 2010; 122: 2131-2141.